Launch week offerEnds in00h00m00s

annual Promonthly Pro

Amanda Psyrri

Professor and Chair

National and Kapodistrian University of Athens

Greece

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Collaborators (20)

Christian Simon

SWITZERLAND

View details

Christos Adamopoulos

Assistant Professor

National and Kapodistrian University of Athens

GREECE

View details

Vassilis L. Souliotis

National and Kapodistrian University of Athens - Faculty of Medicine

GREECE

View details

Konrad Klinghammer

charité university hospital

GERMANY

View details

Antonio Schindler

Docenti

University of Milan

ITALY

View details

Aris Spathis

Assoc. Professor of Molecular Pathology

National and Kapodistrian University of Athens

GREECE

View details

Anna Koumarianou

Chief Consultant Medical Oncologist

University General Hospital Attikon

GREECE

View details

Thazin Nwe Aung

Associate Research Scientist

Yale University

UNITED STATES

View details

Lillian L. Siu

University Health Network

CANADA

View details

Athanassios Vozikis

Professor

University of Piraeus

GREECE

View details

Christophe Le Tourneau

Head of Early Phase Clinical Trials

Institut Curie

FRANCE

View details

Trevor G. Hackman

University of North Carolina at Chapel Hill

UNITED STATES

View details

Paolo Bossi

IRCCS Humanitas Research Hospital

ITALY

View details

Jeppe Friborg

Clinical Research Associate Professor

Københavns Universitet

DENMARK

View details

Kevin Harrington

Head of Division of Radiotherapy and Imaging

Institute of Cancer Research

UNITED KINGDOM

View details

Evi Lianidou

PROFESSOR

National and Kapodistrian University of Athens

GREECE

View details

Caroline Hoffmann

FRANCE

View details

Sung-Bae Kim

University of Ulsan College of Medicine

SOUTH KOREA

View details

Tanguy Seiwert

Johns Hopkins University

UNITED STATES

View details

Makoto Tahara

Chief

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Amanda Psyrri

Research Interests

Make your next move.

Articles (20)

LiGeR-HN phase III trials of petosemtamab + pembrolizumab and petosemtamab monotherapy in recurrent or metastatic HNSCC

Nanoray-312: phase III study of NBTXR3 + radiotherapy ± cetuximab in elderly, platinum-ineligible locally advanced HNSCC

Targeting the PD-1/PD-L1 Signaling Pathway for Cancer Therapy: Focus on Biomarkers

INTERLINK-1: A Phase III, Randomized, Placebo-Controlled Study of Monalizumab plus Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: 5-year follow-up from the randomized phase III KEYNOTE-048 study

International consensus on laryngeal preservation strategies in laryngeal and hypopharyngeal cancer

Association of DNA damage response signals and oxidative stress status with nivolumab efficacy in patients with Head and Neck Squamous Cell Carcinoma

Tumor and blood B-cell abundance outperforms established immune checkpoint blockade response prediction signatures in head and neck cancer

Real-World Toxicity and Effectiveness Study of Abemaciclib in Greek Patients with Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: A Multi-Institutional Study

UVC-Induced Oxidative Stress and DNA Damage Repair Status in Head and Neck Squamous Cell Carcinoma Patients with Different Responses to Nivolumab Therapy

SNF-CLIMEDIN: A HECOG prospective randomized trial of digital support and intervention in patients with advanced non-small cell lung cancer (NSCLC)—Final results.

Detection rate for <i>ESR1</i> mutations is higher in circulating-tumor-cell-derived genomic DNA than in paired plasma cell-free DNA samples as revealed by ddPCR

Detection rate for ESR1 mutations is higher in CTC-derived genomic DNA than in paired plasma cfDNA samples as revealed by ddPCR

Harlequin syndrome in a young patient with osteosarcoma after pleural metastasectomy: A case report and a mini review of the literature

Implementing geriatric assessment for dose Optimization of CDK 4/6-inhibitors in older Breast Cancer patients (IMPORTANT trial) - a pragmatic randomized-controlled trial

Integrating molecular classification in adenoid cystic carcinoma of the head and neck: The experience from four tertiary centers in Greece

NIVOPOSTOP (GORTEC 2018-01): A phase III randomized trial of adjuvant nivolumab added to radio-chemotherapy in patients with resected head and neck squamous cell carcinoma at high risk of relapse.

Real-world study of Abemaciclib in Patients with Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: a Multi-Institutional Prospective Study

Regulation of nucleotide excision repair by wild-type HRAS signaling in head and neck cancer

Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer

Collaborators (20)

Christian Simon

Christos Adamopoulos

Vassilis L. Souliotis

Konrad Klinghammer

Antonio Schindler

Aris Spathis

Anna Koumarianou

Thazin Nwe Aung

Lillian L. Siu

Athanassios Vozikis

Christophe Le Tourneau

Trevor G. Hackman

Paolo Bossi

Jeppe Friborg

Kevin Harrington

Evi Lianidou

Caroline Hoffmann

Sung-Bae Kim

Tanguy Seiwert

Makoto Tahara

Make your next move.